Journal of Developing Drugs

Journal of Developing Drugs
Open Access

ISSN: 2329-6631

+3225889658

Upcoming Special Issue

Purpose: To publish the most exciting research with respect to the subjects of Journal of Developing Drugs and to provide a rapid turn-around time regarding reviewing and publishing, and to disseminate the articles freely for research, teaching and reference purposes.

Special Issue Topics

Special issue entitled: Clinical Trials & Clinical Research is being edited by

  • Michael Beck
    Professor Department for Lysosomal StorageDisorders
    Tel: 496-131-172-398
    Fax: 496-131-175-672
    University of Mainz
    Germany
  • Michael Beck
    Professor
    Department for Lysosomal Storage Disorders
    University of Mainz
    Germany
    logo

Special issue entitled: Drug Designing is being edited by

  • Yavuz S Silay
    Director
    Teva Neuroscience’s Commercial Organization
    Tel: 816-509-86
    USA

Special issue entitled: Epilepsy and its Treatment is being edited by

  • Juan G Ochoa
    Department of Neurology
    Tel: 251-660-5506
    University of South Alabama
    USA
    logo

Special issue entitled: Surgical Infectious Diseases is being edited by

  • Suresh G. Joshi
    Director, Surgical Infections Research & Bacterial Pathogenesis
    Drexel University College of Medicine
    USA
    logo

Special issue entitled: "Drug Development" (Released)

Submission Process

Submit Special Issue articles online through manuscript submission, review and editorial tracking system for quality and quick review processing at https://www.longdom.org/developing-drugs/submit-manuscript.html or send as an e-mail attachment to the editorial office at [email protected]

Note:
  1. In case of online submission, please select "Special Issue Article" from the dropdown list.
  2. In case of e-mail, please specify the title of the special issue in the subject and in the cover letter of the submission.

For further information, Please contact us at: Longdom Publishing SL Journals
: +34 911 877 608
: [email protected]

Top